Developer of a medical device platform designed to improve the treatment of hypervascular tumours. The company is developing novel radiopaque bland embolic and beta radiation emitting radiopaque Y-90 radioembolic agents that will help to improve targeting of tumour vascularity and tumour tissue, enabling doctors to help standardize, optimize and personalize these minimally invasive therapies.abkbiomedical.com
Halifax, NS, Canada
Founded in 2011Inaccurate data? Flag it here.
Open jobs at ABK Biomedical
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.